Levothyroxine Sodium Tablet
Product Images NDC 51655-529

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 529 52 Rev A 01 21)

Label (51655 529 52   Rev A 01 21)
Label for Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), oral tablets. The label indicates a package size of 30 tablets with NDC 51655-529-52. It is a prescription-only medication labeled by Northwind Pharmaceuticals, Indiana. Storage instructions specify 20°-25°C and protection from light and moisture.*
FDA Label Image

Levothyroxine Sodium Structural Formula (Image 13)

Levothyroxine Sodium Structural Formula (Image 13)
Chemical structure of levothyroxine sodium showing iodine-substituted aromatic rings connected via an ether linkage to an amino acid moiety with amine and carboxylate groups, indicating its sodium salt form and associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.